IMNN 8-K 2026-11-12

Imunon, Inc. (IMNN) 8-K dated 2026-11-12 — accession 0001493152-26-051202.

Imunon, Inc. (IMNN) is a biotechnology company listed on US.

Imunon, Inc. filed a 8-K on 2026-11-12. Accession 0001493152-26-051202.

This 8-K covers: Results of operations (Item 2.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported IMNN revenue for 2022-12-31 was $500.0K. Net income was -$35.9M. IMNN currently screens at market cap $9.2M.

Not investment advice. The IMNN SEC hub lists recent forms. The stock page is the research view.